pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

NCT04090528 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Castration-resistant Prostate Cancer
Metastatic Cancer
Prostate Cancer

Interventions

BIOLOGICAL: pTVG-HP
BIOLOGICAL: pTVG-AR
DRUG: Pembrolizumab

Sponsor

University of Wisconsin, Madison

Collaborators

Merck Sharp & Dohme LLC
Madison Vaccines Incorporated
Prostate Cancer Foundation